Abstract
Elacestrant - cancer du sein localement avancé ou métastatique ER+/HER2-, présentant une mutation activatrice d'ESR1
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
Paper Title
Journal
Date